RefleXion Adds Ally Bridge Group to Investor Syndicate

03 Mar, 2021

RefleXion Adds Ally Bridge Group to Investor Syndicate
Photo by Nastuh Abootalebi on Unsplash

– RefleXion Medical announced the successful completion of a $40m Series D financing round bringing total investment in the company to $150m.
– The round was led by Ally Bridge Group (ABG) and includes participation from the company’s executive leadership, NewView Capital, and Georgian Partners.
– RefleXion is pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer.
– RefleXion X1 machine with BgRT is designed to overcome the technical limitations that currently restrict radiotherapy to one or two tumors.
– When available, RefleXion will scale BgRT to treat all visible tumors, even those that move rapidly due to bodily functions such as breathing or digestion, in the same treatment session.

Health Care Medical Medical Device North America Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: